• Quantum BioPharma closed a non-brokered private placement of 26 Class A Multiple Voting Shares on November 9, 2026.
• The placement raised CAD 80.86 at CAD 3.11 per share for general working capital.
• Xorax Family Trust and Fortius Research and Trading Corp. each acquired 13 shares.
• The issuance increased Class A Multiple Voting Shares’ aggregate voting power to approximately 68.22% from 57.01%.
• Securities issued carry a statutory hold period expiring March 10, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-007369), on November 12, 2026, and is solely responsible for the information contained therein.